Old Point Trust & Financial Services N A’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$7.06K 517
2024
Q1
$7.06K Buy
+500
New +$7.06K ﹤0.01% 316
2022
Q3
Sell
-11,650
Closed -$88K 79
2022
Q2
$88K Sell
11,650
-28,900
-71% -$218K 0.04% 78
2022
Q1
$381K Sell
40,550
-1,400
-3% -$13.2K 0.16% 61
2021
Q4
$336K Sell
41,950
-600
-1% -$4.81K 0.14% 63
2021
Q3
$414K Sell
42,550
-6,100
-13% -$59.4K 0.18% 57
2021
Q2
$482K Sell
48,650
-3,500
-7% -$34.7K 0.21% 57
2021
Q1
$602K Buy
52,150
+7,400
+17% +$85.4K 0.28% 52
2020
Q4
$432K Sell
44,750
-500
-1% -$4.83K 0.22% 53
2020
Q3
$408K Hold
45,250
0.22% 55
2020
Q2
$558K Buy
45,250
+1,500
+3% +$18.5K 0.31% 53
2020
Q1
$393K Sell
43,750
-4,250
-9% -$38.2K 0.25% 53
2019
Q4
$470K Sell
48,000
-9,900
-17% -$96.9K 0.22% 59
2019
Q3
$398K Sell
57,900
-2,305
-4% -$15.8K 0.19% 61
2019
Q2
$556K Sell
60,205
-900
-1% -$8.31K 0.28% 56
2019
Q1
$958K Buy
61,105
+1,200
+2% +$18.8K 0.5% 49
2018
Q4
$923K Buy
59,905
+5,000
+9% +$77K 0.54% 47
2018
Q3
$1.18M Buy
54,905
+6,852
+14% +$148K 0.61% 46
2018
Q2
$1.17M Buy
48,053
+5,000
+12% +$122K 0.64% 46
2018
Q1
$736K Sell
43,053
-6,350
-13% -$109K 0.42% 53
2017
Q4
$937K Sell
49,403
-4,102
-8% -$77.8K 0.51% 52
2017
Q3
$942K Buy
53,505
+5,000
+10% +$88K 0.53% 50
2017
Q2
$1.61M Sell
48,505
-100
-0.2% -$3.32K 0.93% 38
2017
Q1
$1.56M Buy
48,605
+4,200
+9% +$135K 0.9% 39
2016
Q4
$1.61M Sell
44,405
-950
-2% -$34.4K 0.96% 37
2016
Q3
$2.09M Buy
45,355
+150
+0.3% +$6.9K 1.28% 29
2016
Q2
$2.27M Sell
45,205
-850
-2% -$42.7K 1.41% 29
2016
Q1
$2.46M Sell
46,055
-50
-0.1% -$2.68K 1.54% 27
2015
Q4
$3.03M Buy
46,105
+1,900
+4% +$125K 1.97% 23
2015
Q3
$2.5M Sell
44,205
-550
-1% -$31.1K 1.77% 23
2015
Q2
$2.65M Buy
44,755
+1,200
+3% +$70.9K 1.72% 26
2015
Q1
$2.71M Buy
43,555
+5
+0% +$311 1.75% 26
2014
Q4
$2.51M Buy
43,550
+1,300
+3% +$74.8K 1.51% 28
2014
Q3
$2.27M Buy
42,250
+3,950
+10% +$212K 1.36% 28
2014
Q2
$2.01M Buy
38,300
+1,400
+4% +$73.4K 1.2% 31
2014
Q1
$1.95M Buy
+36,900
New +$1.95M 1.22% 31